Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Literature DB >> 15243097

Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Naoko Nakagawa¹, Ritsuko Kubota, Akiko Maeda, Yoshinobu Okuno.

Abstract

In the 2002-2003 season, influenza B virus Victoria strains were epidemic after a 6-year absence in Kobe City, Japan. They reacted poorly to the immune ferret sera prepared for use against the previous strain. An amino acid substitution in the HA1 region caused them to acquire an N-linked glycosylation site.

Entities: Chemical Species

Mesh：

Year: 2004 PMID： 15243097 PMCID： PMC446311 DOI： 10.1128/JCM.42.7.3295-3297.2004

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

18 in total

1. Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'.

Authors: Naoko Nakagawa; Ritsuko Kubota; Toshimasa Nakagawa; Yoshinobu Okuno
Journal: J Gen Virol Date: 2003-04 Impact factor: 3.891

2. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

Authors: P A Rota; T R Wallis; M W Harmon; J S Rota; A P Kendal; K Nerome
Journal: Virology Date: 1990-03 Impact factor: 3.616

3. Influenza B virus in seals.

Authors: A D Osterhaus; G F Rimmelzwaan; B E Martina; T M Bestebroer; R A Fouchier
Journal: Science Date: 2000-05-12 Impact factor: 47.728

4. Characterization of new epidemic strains of influenza B virus by using neutralizing monoclonal antibodies.

Authors: N Nakagawa; R Kubota; S Morikawa; T Nakagawa; K Baba; Y Okuno
Journal: J Med Virol Date: 2001-12 Impact factor: 2.327

5. Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences.

Authors: N Nakagawa; R Kubota; A Maeda; T Nakagawa; Y Okuno
Journal: J Clin Microbiol Date: 2000-09 Impact factor: 5.948

6. Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule.

Authors: Emi Tsuchiya; Kanetsu Sugawara; Seiji Hongo; Yoko Matsuzaki; Yasushi Muraki; Zhu-Nan Li; Kiyoto Nakamura
Journal: J Gen Virol Date: 2002-05 Impact factor: 3.891

7. Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses.

Authors: M Yamashita; M Krystal; W M Fitch; P Palese
Journal: Virology Date: 1988-03 Impact factor: 3.616

8. Emergence of an influenza B virus with antigenic change.

Authors: Naoko Nakagawa; Souichi Nukuzuma; Shigekazu Haratome; Shosan Go; Toshimasa Nakagawa; Kozaburo Hayashi
Journal: J Clin Microbiol Date: 2002-08 Impact factor: 5.948

9. Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies.

Authors: M T Berton; C W Naeve; R G Webster
Journal: J Virol Date: 1984-12 Impact factor: 5.103

10. Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies.

Authors: W Gerhard; R G Webster
Journal: J Exp Med Date: 1978-08-01 Impact factor: 14.307

14 in total

1. Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.

Authors: Naoko Nakagawa; Ritsuko Kubota; Yoshinobu Okuno
Journal: J Clin Microbiol Date: 2005-08 Impact factor: 5.948

2. Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.

Authors: Naoko Nakagawa; Jun Suzuoki; Ritsuko Kubota; Shinzo Kobatake; Yoshinobu Okuno
Journal: J Clin Microbiol Date: 2006-04 Impact factor: 5.948

3. Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan.

Authors: Naoko Nakagawa; Natsumi Higashi; Toshimasa Nakagawa
Journal: J Clin Microbiol Date: 2008-12-17 Impact factor: 5.948

4. The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus.

Authors: Fengyun Ni; Innocent Nnadi Mbawuike; Elena Kondrashkina; Qinghua Wang
Journal: Virology Date: 2013-12-22 Impact factor: 3.616

5. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.

Authors: Elisabetta Bianchi; Xiaoping Liang; Paolo Ingallinella; Marco Finotto; Michael A Chastain; Jiang Fan; Tong-Ming Fu; Hong Chang Song; Melanie S Horton; Daniel C Freed; Walter Manger; Emily Wen; Li Shi; Roxana Ionescu; Colleen Price; Marc Wenger; Emilio A Emini; Riccardo Cortese; Gennaro Ciliberto; John W Shiver; Antonello Pessi
Journal: J Virol Date: 2005-06 Impact factor: 5.103